BIIB

BIOGEN INC

Healthcare | Large Cap

$2.45

EPS Forecast

$2,727

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-12-31

Proximilar's AI forecasts

EPS Forecast:

$2.45

Revenue Forecast:

$2,727

EPS Surprise Forecast:

$0.389

Revenue Surprise Forecast:

$132

Post-release price volatility - Medium

Post-release Overnight Move:

±5.7%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

94%

Probability of beating revenue consensus:

95%

Probability of beating both EPS & revs consensus:

90%

Probability of missing both EPS & revs consensus:

1%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

4

Beta (β)

Forward Looking Beta (β):

0.64

Earnings volatility

EPS standard deviation:

$0.45

Revenue standard deviation:

$109

As % of share price:

0.21% MEDIUM

As % of market cap:

0.34% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

$3.10

Revenue 95th %ile:

$2,889

EPS 75th %ile:

$2.62

Revenue 75th %ile:

$2,772

EPS 25th %ile:

$2.33

Revenue 25th %ile:

$2,689

EPS 5th %ile:

$2.02

Revenue 5th %ile:

$2,596

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

45% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

27% HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$11

Bid-ask per Share:

$0.23